$62.88
Vascular Anatomy · Risk Factors · Conditions · Glossary · Investor Relations. Expand. Press Releases · Webcasts · Investor Calendar · Stock Information ...
Vascular disease isn't going away. Real people continue to fight the progression and complications that result from PAD. We've won many battles but the war ...
BURLINGTON, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2023 ...
Home»Investor Relations ... vascular and portable medical markets. The ... Investor Contact. Andrew Senn, Senior Vice President, Strategy, Business Development and ...
AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc. LATHAM, N.Y. --(BUSINESS WIRE)--Apr. 1, 2024-- AngioDynamics, Inc. (NASDAQ: ...
The Investor Relations website contains information about Silk Road Medical, Inc.'s business for stockholders, potential investors, and financial analysts.
The Investor Relations website contains information about Humacyte, Inc.'s business for stockholders, potential investors, and financial analysts.
Stay informed on Medistim's financial performance, including reports, presentations, and shareholder news.
Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine ...
Our purpose is to develop simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with diseases of ...